Immunogenicity & Antigenicity-Based T-Cell & Epitopes Identification for Design of Biologic Therapeutics

Time: 10:00 am
day: Day One


  • In silico analysis as an integrative approach for the assessment of immunogenicity in the pre-clinical phase
  • In vitro validation study to offer predictive insights on immunogenicity of biotherapeutics
  • Remaining challenges to offer better predictive insights to mitigate clinical immunogenicity risk of biotherapeutics